Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Memorial Sloan Kettering Cancer Center

Clinical trials sponsored by Memorial Sloan Kettering Cancer Center, explained in plain language.

Trials to join now! 305 Not yet recruiting 4 Not yet finished but already full! 335 Completed 81 Terminated 1

Experimental drug tested for rare cancer, trial stopped early

Disease control Terminated

This study tested a drug called XmAb23104 in people with advanced sarcoma, a rare cancer. The goal was to see if the drug could shrink tumors and if it was safe. Only 6 people took part before the study was ended early.

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:07 UTC